Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 189.38% | -112.88% | 131.14% | -85.95% | 365.10% |
| Total Depreciation and Amortization | -2.28% | -9.13% | 13.68% | -22.34% | 110.00% |
| Total Amortization of Deferred Charges | 2.32% | 0.22% | 41.68% | 0.11% | 41.23% |
| Total Other Non-Cash Items | -848.26% | 102.51% | -109.04% | 83.60% | -317.74% |
| Change in Net Operating Assets | 98.95% | -10.08% | -35.14% | 39.54% | 238.15% |
| Cash from Operations | 41.96% | -10.30% | -10.48% | 43.40% | 17.99% |
| Capital Expenditure | -- | 100.00% | -1,248.84% | 6.52% | 77.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 560.00% | -162.50% | 66.67% | 86.96% | 24.59% |
| Cash from Investing | 560.00% | 83.06% | -280.37% | 83.13% | 32.07% |
| Total Debt Issued | -27.29% | 117.76% | -55.06% | -30.46% | -33.88% |
| Total Debt Repaid | -34.47% | 6.84% | -85.03% | -326.32% | 83.19% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -70.46% | -- | -- | -- |
| Cash from Financing | -64.32% | 26.45% | -20.20% | -41.23% | -27.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -397.14% | 104.17% | -281.82% | 910.53% | -111.70% |